Relief Therapeutics Holding AG

Relief Therapeutics Holding AG - PE Ratioverified

RLFTD

Price:

$4.08

Market Cap:

$36.29M

Relief Therapeutics Holding AG operates as a biopharmaceutical firm, dedicated to providing vital therapeutic relief to patients suffering from severe diseases for which current medical solutions are insufficient. The company's reach extends across Switzerland, the broader European continent, North America, and various international markets. Its strategic focus is on advancing clinical-stage programs that leverage molecules with a proven history of clinical application. These programs are supported by either initial evidence of human biological activity or efficacy, or a strong scientific rationale. A key asset in their development pipeline is RLF-100, also known as aviptadil. This synthetic...[Read more]

Industry

Biotechnology

IPO Date

2021-11-23

Stock Exchange

OTC

Ticker

RLFTD

The PE Ratio as of June 2026 (TTM) for Relief Therapeutics Holding AG (RLFTD) is -0.77

According to Relief Therapeutics Holding AG’s latest financial reports and current stock price. The company's current PE Ratio is -0.77. This represents a change of 5.31% compared to the average of -0.73 of the last 4 quarters.

Relief Therapeutics Holding AG (RLFTD) Historical PE Ratio (quarterly & annually)

How has RLFTD PE Ratio performed in the past?

The mean historical PE Ratio of Relief Therapeutics Holding AG over the last ten years is -11.89. The current -0.77 PE Ratio has changed 546.26% with respect to the historical average. Over the past ten years (40 quarters), RLFTD's PE Ratio was at its highest in in the June 2020 quarter at 1.16. The PE Ratio was at its lowest in in the December 2006 quarter at -475.92.

Quarterly (TTM)
Annual

Average

-11.89

Median

-2.58

Minimum

-86.74

Maximum

-0.31

Relief Therapeutics Holding AG (RLFTD) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Relief Therapeutics Holding AG PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 776.45%

Maximum Annual PE Ratio = -0.31

Minimum Annual Increase = -94.10%

Minimum Annual PE Ratio = -86.74

Quarterly (TTM)
Annual
YearPE RatioChange
2024-2.03560.73%
2023-0.31-75.33%
2022-1.24-60.35%
2021-3.14-38.69%
2020-5.120.09%
2019-5.11-94.10%
2018-86.74589.90%
2017-12.57776.45%
2016-1.4319.49%
2015-1.2068.13%

Relief Therapeutics Holding AG (RLFTD) Average PE Ratio

How has RLFTD PE Ratio performed in the past?

The current PE Ratio of Relief Therapeutics Holding AG (RLFTD) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-1.19

5-year avg

-2.37

10-year avg

-11.89

Relief Therapeutics Holding AG (RLFTD) PE Ratio vs. Peers

How is RLFTD’s PE Ratio compared to its peers?

Relief Therapeutics Holding AG’s PE Ratio is greater than Abliva AB (publ) (-4.91), greater than Medivir AB (publ) (-4.51), greater than Small Pharma Inc. (-2.23), greater than Alpha Cognition Inc. (-39.22), greater than Oncopeptides AB (publ) (-1.73), less than LakeShore Biopharma Co., Ltd (-0.48), less than MedPeer,Inc. (34.66), greater than Mindset Pharma Inc. (-4.01), greater than Assisted 4 Living, Inc. (-123.81), greater than Herantis Pharma Oyj (-6.94),

Build a custom stock screener for Relief Therapeutics Holding AG (RLFTD) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Relief Therapeutics Holding AG using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Relief Therapeutics Holding AG (RLFTD) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Relief Therapeutics Holding AG or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Relief Therapeutics Holding AG's PE Ratio?

How is the PE Ratio calculated for Relief Therapeutics Holding AG (RLFTD)?

What is the highest PE Ratio for Relief Therapeutics Holding AG (RLFTD)?

What is the 3-year average PE Ratio for Relief Therapeutics Holding AG (RLFTD)?

What is the 5-year average PE Ratio for Relief Therapeutics Holding AG (RLFTD)?

How does the current PE Ratio for Relief Therapeutics Holding AG (RLFTD) compare to its historical average?